期刊文献+

1例t(15;17)的急性早幼粒细胞白血病复发后核型演变成ins(17;15)的病例报道并文献复习 被引量:4

Acute promyelocytic leukaemia with t (15;17) but karyotype evolved into ins (17;15) after replase:a case report and lliterature review
原文传递
导出
摘要 目的:报道1例罕见的初诊为t(15;17)的急性早幼粒细胞白血病复发后演变成ins(17;15)的病例,并探讨其临床和实验室特点。方法:骨髓细胞经直接法和24h培养法制备染色体标本,以R显带技术进行核型分析;采用染色体15号和17号位点特异双色双融合PML/RARa基因探针进行荧光原位杂交。结果:该患者初诊时染色体核型分析结果为t(15;17)(q22;q12),荧光原位杂交结果显示2红2绿1融合(2R2G1F)的异常信号。经诱导化疗及巩固治疗后,达到完全缓解,但是1年后复发,核型演变成ins(17;15)(q12;q14q22),7个月后又第2次复发。结论:ins(17;15)可以从t(15;17)的核型演变而来,可能提示病情恶化,预后不佳。 Objective:To report an acute promyelocytic leukaemia(APL)case with t(15;17)karyotype evolving into ins(17;15)after relapse,and review its clinical and laboratory characteristics.Method:Chromosome specimens were prepared using direct method or 24 hculture of bone marrow cells.R-banding technique was used to analyze karyotypes.Fluorescence in situ hybridization(FISH)analysis was performed using chromosome 15 and 17site specific dual fusion PML/RARa gene probe.Result:The patient’s chromosome karyotype at initial diagnosis was t(15;17)(q22;q12)and FISH results showed abnormal signal of 2R2G1 F.The patient received induction and consolidation therapy after complete remission,but karyotype evolved into ins(17;15)(q12;q14q22)when he relapsed after 1year and second relapsed 7months later.Conclusion:Ins(17;15)can evolve from t(15;17),which may indicate deterioration and poor prognosis of the disease.
出处 《临床血液学杂志》 CAS 2016年第1期55-56,共2页 Journal of Clinical Hematology
关键词 急性早幼粒细胞白血病 染色体核型分析 变异型插入易位 acute promyelocytic leukaemia chromosome karyotype variant insertion translocation
  • 相关文献

参考文献4

二级参考文献8

  • 1马军.三氧化二砷治疗急性早幼粒细胞白血病的回顾及进展[J].国际输血及血液学杂志,2007,30(3):210-213. 被引量:10
  • 2Ribeiro RC, Rego E. Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration. Hematology Am Soc Hematol Educ Program, 2006 : 162-168.
  • 3Pallisgaard N, Hokland P, Riishφj DC, el al. Multiplex reverse transeription polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood,1998,92(2) :574-588.
  • 4Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood,2008,111(5):2505-2515.
  • 5Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatement of acute promyelocytic leukemia. Haematol Blood Transfus, 1989,32 : 88-96.
  • 6Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As203)in the treatment of acute promyelocytie leukemia (APL): Ⅱ. clinical efficay and pharmacokineties in relapsed patients, 1997,89 (9) : 3354-3360.
  • 7Wouters BJ, Lowenberg B, Delwel R. A decade of genomewide gene expression profiling in acute myeloid leukemia: flashback ang prosopects. Blood,2009,113(2) :291-298.
  • 8Heuser M, Argiropoulos B, Kuchenbauer F, et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood, 2007, 110(5):1639-1647.

共引文献84

同被引文献14

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部